Europe Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography
Market Introduction
The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.
Get more information on this report : 
Market Overview and Dynamics
TheEuropecell line development market is expected to reach US$ 3,187.57million in 2027 from US$ 1,214.01million in 2019. The market is estimated to grow with a CAGR of 13.0% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such asthe increasing government participation in the cell line development market and an upsurge in the development of the biotechnology industry. However, the market growth is likely to be hindered owing to the contamination of the cell line by microorganisms.
Key Market Segments
Based on type, the cell line development market is segmented intoprimary cell line, hybridomas, continuous cell lines, and recombinant cell line.Based on product, the cell line development market is segmented intoequipment, and media & reagent.Based on application, the cell line development market, is segmented intodrug discovery, bioproduction, and tissue engineering.
Major Sources and Companies Listed
Some of the major primary and secondary sources forcell line development market included in the report areUK Stem Cell Foundation, European Forum for Industrial Biotechnology and the Bioeconomy (EFIB),Biotechnology and Biological Sciences Research Council (BBSRC), and others.
Reasons to buy the report
- To understand the Europe cell line development market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for cell line development market
- Efficiently plan M&A and partnership deals in Europe cell line development market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment formcell line development market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region
EUROPECELL LINE DEVELOPMENT MARKET SEGMENTATION
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
- Equipment
- Media & Reagent
By Country
- Europe
Company Profiles
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cell line development Market – By Type
1.3.2 Cell line development Market – By Product
1.3.3 Cell line development Market – By Application
1.3.4 EuropeCell line development Market – By Country
2. Europe Cell Line Development Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EuropeCell Line Development Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Cell Line Development Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Government Participation in the Cell Line Development Market
5.1.2 An Upsurge in the Development of the Biotechnology Industry
5.2 Market Restraints
5.2.1 Contamination of Cell Line by Microorganisms
5.3 Market Opportunity
5.3.1 Increasing Technological Advancements Regarding Cell Line Development
5.4 Future Trend
5.4.1 Growing Development of Innovative Products in the Cell Line Development Market
5.5 Impact Analysis
6. Cell Line Development Market – Europe Analysis
6.1 EuropeCell Line Development Market Revenue Forecasts and Analysis
7. EuropeCell Line Development Market Analysis and Forecasts To 2027 – ByType
7.1 Overview
7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
7.3 Primary Cell Line
7.3.1 Overview
7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Hybridomas
7.4.1 Overview
7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Continuous Cell Lines
7.5.1 Overview
7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Recombinant Cell Line
7.6.1 Overview
7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Cell Line Development Market Analysis and Forecasts To 2027 – ByProduct
8.1 Overview
8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
8.3 Equipment
8.3.1 Overview
8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Media and Reagent
8.4.1 Overview
8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
9. Europe Cell Line Development Market Analysis – ByApplication
9.1 Overview
9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Bioproduction
9.4.1 Overview
9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Tissue Engineering
9.5.1 Overview
9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
10. Cell Line Development Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Europe Cell Line Development Market Revenue and Forecast to 2027
10.1.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.6 Germany
10.1.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.7 UK
10.1.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8 France
10.1.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9 Spain
10.1.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.10 Italy
10.1.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11. Impact of COVID-19 Pandemic on EuropeCell Line Development Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Information
12.2.4 Product /Services Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 SELEXIS
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product/Service Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 WuXi AppTec
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Service Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lonza
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Corning Incorporated
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of terms
LIST OF TABLES
Table 1. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 3. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 4. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 5. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 6. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 9. UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 10. France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11. France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 12. France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 15. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 16. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 17. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 18. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 19. Glossary of Terms, Cell Line Development Market
LIST OF FIGURES
Figure 1. Cell Line DevelopmentMarket Segmentation
Figure 2. EuropeCell Line Development Market Overview
Figure 3. Recombinant Cell Line Segment Held Largest Share of Typein Cell Line DevelopmentMarket
Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cell Line Development Market - Europe PEST Analysis
Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
Figure 7. EuropeCell Line Development Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. Media and ReagentMarket Revenue and Forecast to 2027 (US$ Mn)
Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. Europe Cell Line Development Market Revenue, By Country, 2019 (US$ Mn)
Figure 21. Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 22. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 23. Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 24. UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 25. France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 28. Impact of COVID-19 Pandemic in Europe Country Markets
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SELEXIS
- WuXiAppTec
- General Electric
- Lonza
- Corning Incorporated
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.